Clinical Trial Update: Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for relapsed or refractory primary diffuse large B-cell lymphoma of the central nervous system; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma of the Central Nervous System

Snippet

Sponsor: Seoul National University Hospital | Conditions: DLBCL | Phase 2 | Status: ACTIVE_NOT_RECRUITING